| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.045 | 0.7 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |